
Ralifen-AQ Injection
Marketer
Foral Healthcare
Salt Composition
Diclofenac (75mg)
Overview Ralifen-AQ Injection
Aquafen Ral injection offers pain relief and is indicated for managing pain, inflammation, rigidity, and arthralgia associated with conditions such as rheumatoid and osteoarthritis, and acute musculoskeletal trauma. Parenteral administration is necessary when oral intake is infeasible. This injectable medication must be administered by a qualified healthcare provider; self-injection is strictly prohibited. Patients with a history of cardiovascular events (e.g., heart disease, stroke) should disclose this information to their physician. Seek immediate medical attention should injection site reactions, such as localized pain, swelling, or erythema, develop. Common adverse effects include nausea, emesis, cephalalgia, and injection site reactions. Prolonged therapy may necessitate regular monitoring of renal and hepatic function, along with hematological parameters. Chronic use carries a risk of severe complications, including gastrointestinal bleeding and nephropathy.
Primary Ingredients of Ralifen-AQ Injection
No text provided to rephrase.
Uses of Ralifen-AQ Injection
Analgesia
Major Benefits of Ralifen-AQ Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
Common Side effects of Ralifen-AQ Injection:
- Injection site reactions (pain, swelling, redness)
- Vomiting
- Flatulence
- Edema (swelling)
- Nausea
- Headache
- Dizziness
How to use Ralifen-AQ Injection:
The medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
How Ralifen-AQ Injection works:
Ralifen-AQ Injection is a non-steroidal anti-inflammatory drug (NSAID) that inhibits the production of inflammatory mediators responsible for pain and associated symptoms like redness and edema.
SAFETY ADVICE
AlcoholCAUTION
Exercise caution when using Ralifen-AQ Injection concurrently with alcohol. Physician consultation is recommended.
PregnancyCONSULT YOUR DOCTOR
Administering Ralifen-AQ Injection during pregnancy is contraindicated due to established harm to the fetus. Nevertheless, in exceptional, life-threatening circumstances, a physician might prescribe it if the potential advantages outweigh the known risks. Physician consultation is essential.
Breast feedingCONSULT YOUR DOCTOR
Administration of Ralifen-AQ Injection while breastfeeding is likely inadvisable. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Administering Ralifen-AQ Injection might impair driving capabilities due to potential adverse reactions.
KidneyCAUTION
Exercise caution when administering Ralifen-AQ Injection to individuals with impaired renal function. Dosage modification of Ralifen-AQ Injection might be necessary. Physician consultation is recommended.
LiverCAUTION
Administering Ralifen-AQ Injection to patients with hepatic impairment requires careful consideration. Dosage modification for Ralifen-AQ Injection may be necessary. Physician consultation is advised.
What if you forget to take Ralifen-AQ Injection :
Omit a Ralifen-AQ Injection dose? Seek your physician's advice.
Facts to Know About Ralifen-AQ Injection
| Label | Value |
|---|---|
| Chemical Category | Phenylacetic Acid Analog |
| Developing Habits | No. |
| Treatment Category | Pain Relievers |
